Clinical Trials Browser

Withdrawn × Advanced Cancers × Clear all

NCT02193672 2014-07-18

A Pilot, Exploratory, Non-Randomized Study of PET/CT With the Investigational Agent [18F] Fluciclatide to Correlate With Response to Anti-Cancer Therapy

Phase 1 Withdrawn

Advanced Cancers

NCT01432119 2013-04-09

Phase 1 Trial With SIR-Spheres and Cetuximab +/- Erlotinib

Phase 1 Withdrawn

Advanced Cancers

NCT01608139 2012-10-19

Study of Curcumin, Vorinostat, and Sorafenib

Phase 1 Withdrawn

Advanced Cancers